Cooperation of Oncolytic Herpes Virotherapy and PD-1 Blockade in Murine Rhabdomyosarcoma Models
Abstract Oncolytic virotherapy is an effective immunotherapeutic approach for cancer treatment via a multistep process including direct tumor cell lysis, induction of cytotoxic or apoptosis-sensitizing cytokines and promotion of antitumor T cell responses. Solid tumors limit the effectiveness of imm...
Enregistré dans:
Auteurs principaux: | Chun-Yu Chen, Pin-Yi Wang, Brian Hutzen, Les Sprague, Hayley M. Swain, Julia K. Love, Joseph R. Stanek, Louis Boon, Joe Conner, Timothy P. Cripe |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Nature Portfolio
2017
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/fdcd41e11f1d41dba014f2f0f98645df |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
- Oncolytic Virotherapy
-
Oncolytic Virotherapy
Publié: (2016) -
Oncolytic Virotherapy: From Bench to Bedside
par: Ludi Yang, et autres
Publié: (2021) -
Adjuvant oncolytic virotherapy for personalized anti-cancer vaccination
par: D. G. Roy, et autres
Publié: (2021) -
Oncolytic virotherapy induced CSDE1 neo-antigenesis restricts VSV replication but can be targeted by immunotherapy
par: Timothy Kottke, et autres
Publié: (2021)